Gene: SCYGR9
Official Full Name: small cysteine and glycine repeat containing 9 (pseudogene)provided by HGNC
Gene Summary: Predicted to be located in intermediate filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14276 | SCYGR9 Knockout cell line (HeLa) | Human | SCYGR9 | 1:3~1:6 | Negative | Online Inquiry |
KO14277 | SCYGR9 Knockout cell line (HCT 116) | Human | SCYGR9 | 1:2~1:4 | Negative | Online Inquiry |
KO14278 | SCYGR9 Knockout cell line (HEK293) | Human | SCYGR9 | 1:3~1:6 | Negative | Online Inquiry |
KO14279 | SCYGR9 Knockout cell line (A549) | Human | SCYGR9 | 1:3~1:4 | Negative | Online Inquiry |
SCYGR9 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the investigation of gene functions and pathways associated with the SCYGR9 gene. These knockout cell lines have undergone precise genetic engineering to disrupt the SCYGR9 gene, allowing researchers to study the resulting phenotypic changes and elucidate the gene's role in various biological processes. This systematic approach aids in understanding the molecular mechanisms underlying diseases, facilitating the discovery of potential therapeutic targets.
The key function of SCYGR9 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for the examination of gene expression profiles, signaling pathways, and cellular responses to different stimuli. By eliminating the SCYGR9 gene, researchers can pinpoint the gene's contribution to cellular functions and interactions, thereby gaining insights into its involvement in processes such as cell proliferation, differentiation, or apoptosis. These engineered cells serve as a valuable tool for both basic and applied research, allowing for elucidation of the biological implications of SCYGR9 in health and disease.
In terms of scientific importance, these cell lines are valuable for applications in both research and clinical settings. They enable the validation of hypotheses regarding gene functions in various disease models, including cancer and genetic disorders. Moreover, SCYGR9 Gene Knockout Cell Lines can aid in drug discovery and development by enabling high-throughput screening of potential therapeutic agents targeting associated pathways.
The unique selling points of SCYGR9 Gene Knockout Cell Lines include their replicable knockout efficiency, customization potential, and ease of use. Unlike traditional methods, which may involve labor-intensive and time-consuming procedures, these optimized cell lines provide researchers with a straightforward approach to investigate gene functions without the possibility of off-target effects common in other gene-editing techniques. As a result, they allow for more reliable and reproducible experimental outcomes.
By incorporating SCYGR9 Gene Knockout Cell Lines into their research, scientists and clinicians can enhance their understanding of gene-related mechanisms, ultimately translating into the development of innovative therapies and treatment strategies. Our company has a longstanding commitment to providing high-quality biological products that support cutting-edge research. Our expertise ensures that researchers have access to the most reliable and effective cellular models needed to advance their work in gene function studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.